Detalles de la búsqueda
1.
Dose-escalated simultaneous integrated boost radiotherapy in early breast cancer (IMPORT HIGH): a multicentre, phase 3, non-inferiority, open-label, randomised controlled trial.
Lancet
; 401(10394): 2124-2137, 2023 06 24.
Artículo
en Inglés
| MEDLINE | ID: mdl-37302395
2.
International Society of Urological Pathology (ISUP) Gleason Grade Groups stratify outcomes in the CHHiP Phase 3 prostate radiotherapy trial.
BJU Int
; 133(2): 179-187, 2024 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-37463104
3.
Observation versus screening spinal MRI and pre-emptive treatment for spinal cord compression in patients with castration-resistant prostate cancer and spinal metastases in the UK (PROMPTS): an open-label, randomised, controlled, phase 3 trial.
Lancet Oncol
; 23(4): 501-513, 2022 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-35279270
4.
Challenges for breast radiotherapy with SIB: the IMPORT HIGH trial - Authors' reply.
Lancet
; 403(10438): 1752, 2024 May 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-38704171
5.
Linkage of the CHHiP randomised controlled trial with primary care data: a study investigating ways of supplementing cancer trials and improving evidence-based practice.
BMC Med Res Methodol
; 20(1): 198, 2020 07 25.
Artículo
en Inglés
| MEDLINE | ID: mdl-32711460
6.
Intensity-modulated fractionated radiotherapy versus stereotactic body radiotherapy for prostate cancer (PACE-B): acute toxicity findings from an international, randomised, open-label, phase 3, non-inferiority trial.
Lancet Oncol
; 20(11): 1531-1543, 2019 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-31540791
7.
Partial-breast radiotherapy after breast conservation surgery for patients with early breast cancer (UK IMPORT LOW trial): 5-year results from a multicentre, randomised, controlled, phase 3, non-inferiority trial.
Lancet
; 390(10099): 1048-1060, 2017 Sep 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-28779963
8.
Conventional versus hypofractionated high-dose intensity-modulated radiotherapy for prostate cancer: 5-year outcomes of the randomised, non-inferiority, phase 3 CHHiP trial.
Lancet Oncol
; 17(8): 1047-1060, 2016 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-27339115
9.
Hypofractionated radiotherapy versus conventionally fractionated radiotherapy for patients with intermediate-risk localised prostate cancer: 2-year patient-reported outcomes of the randomised, non-inferiority, phase 3 CHHiP trial.
Lancet Oncol
; 16(16): 1605-16, 2015 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-26522334
10.
Multi-candidate immunohistochemical markers to assess radiation response and prognosis in prostate cancer: results from the CHHiP trial of radiotherapy fractionation.
EBioMedicine
; 88: 104436, 2023 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-36708693
11.
TORPEdO: A phase III trial of intensity-modulated proton beam therapy versus intensity-modulated radiotherapy for multi-toxicity reduction in oropharyngeal cancer.
Clin Transl Radiat Oncol
; 38: 147-154, 2023 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-36452431
12.
Nonrandomized Comparison of Efficacy and Side Effects of Bicalutamide Compared With Luteinizing Hormone-Releasing Hormone (LHRH) Analogs in Combination With Radiation Therapy in the CHHiP Trial.
Int J Radiat Oncol Biol Phys
; 113(2): 305-315, 2022 06 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-35017008
13.
PEARLS - A multicentre phase II/III trial of extended field radiotherapy for androgen sensitive prostate cancer patients with PSMA-avid pelvic and/or para-aortic lymph nodes at presentation.
Clin Transl Radiat Oncol
; 37: 130-136, 2022 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-36238579
14.
Early versus delayed treatment of relapsed ovarian cancer (MRC OV05/EORTC 55955): a randomised trial.
Lancet
; 376(9747): 1155-63, 2010 Oct 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-20888993
15.
Interferon alfa-2a versus combination therapy with interferon alfa-2a, interleukin-2, and fluorouracil in patients with untreated metastatic renal cell carcinoma (MRC RE04/EORTC GU 30012): an open-label randomised trial.
Lancet
; 375(9715): 641-8, 2010 Feb 20.
Artículo
en Inglés
| MEDLINE | ID: mdl-20153039
16.
Dose-escalated intensity-modulated radiotherapy in patients with locally advanced laryngeal and hypopharyngeal cancers: ART DECO, a phase III randomised controlled trial.
Eur J Cancer
; 153: 242-256, 2021 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-34256319
17.
PIVOTALboost: A phase III randomised controlled trial of prostate and pelvis versus prostate alone radiotherapy with or without prostate boost (CRUK/16/018).
Clin Transl Radiat Oncol
; 25: 22-28, 2020 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-32995575
18.
Evaluation of erectile potency and radiation dose to the penile bulb using image guided radiotherapy in the CHHiP trial.
Clin Transl Radiat Oncol
; 21: 77-84, 2020 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-32072028
19.
A randomised assessment of image guided radiotherapy within a phase 3 trial of conventional or hypofractionated high dose intensity modulated radiotherapy for prostate cancer.
Radiother Oncol
; 142: 62-71, 2020 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-31767473
20.
Protocol for tumour-focused dose-escalated adaptive radiotherapy for the radical treatment of bladder cancer in a multicentre phase II randomised controlled trial (RAIDER): radiotherapy planning and delivery guidance.
BMJ Open
; 10(12): e041005, 2020 12 31.
Artículo
en Inglés
| MEDLINE | ID: mdl-33384390